Upstream Bio Inc Sustainability Reports
Upstream Bio, Inc. is a clinical-stage biotechnology company that develops treatments for inflammatory diseases. Its primary clinical focus is on severe respiratory disorders, utilizing therapies such as verekitug to target neuroimmune and inflammatory pathways.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG017Y2X950
1 reports from 2024 to 2024
Company Profile
Upstream Bio, Inc. is a clinical-stage biotechnology company that develops treatments for inflammatory diseases. Its primary clinical focus is on severe respiratory disorders, utilizing therapies such as verekitug to target neuroimmune and inflammatory pathways.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years